Lillienfeld, "Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors
," Hypertension, vol.
Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitors
. Vox Sang.
"National patterns of angiotensin-converting enzyme inhibitor
use in congestive failure." Arch intern Med.
Characteristics of patient groups Systolic dysfunction Yes No (n = 58) (n = 57) Age, mean (SD) 81.5 (5.8) 79.7 (5.8) Male 30% 33% Ischaemic heart disease 59% 56% Acute MI 5% 21% Hypertension 14% 25% Atrial fibrillation 30% 48% Valvular disease 19% 32% Aortic stenosis 2% 14% Discharge ACEI 78% 63% Failed ACEI trial 12% 7% No echocardiogram (n = 186) Age, mean (SD) 82.9 (7.1) Male 35% Ischaemic heart' disease 46% Acute MI 4% Hypertension 16% Atrial fibrillation 28% Valvular disease 2% Aortic stenosis 0% Discharge ACEI 48% Failed ACEI trial 4% ACEI, angiotensin-converting enzyme inhibitor
; MI, myocardial infarct.
Once heart failure has been diagnosed and appropriate treatment started, the cough should go away If it returns, your medications may need adjusting or your angiotensin-converting enzyme inhibitor
changed to an angiotensin receptor blocker.
Angiotensin-converting enzyme inhibitor
(ACE-I) angio-oedema was considered, [2-5] as ACE-I angio-oedema may develop months or even years after commencing therapy.
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor
and a beta-blocker on blood pressure reduction.
The aim of this study was to elucidate the combined effect of the clinically used vitamin K(2) (VK) and angiotensin-converting enzyme inhibitor
(ACE-I) on cumulative recurrence after curative treatment on a total of 87 patients, especially in consideration of neovascularization.METHODS: VK (menatetrenone; 45 mg/day) and/or ACE-I (perindopril; 4 mg/day) were administered for 36-48 months after curative therapy for HCC.
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting enzyme inhibitor
in non-diabetic renal disease (COOPERATE): a randomised controlled clinical trial.
To start treatment according the algorithm, which called for a low-dose (half tablet) of a marketed formulation that combined a diuretic with either an angiotensin-converting enzyme inhibitor
or an angiotensin-receptor blocker, physicians could choose among 11 formulations that were on the Canadian market at the time the study began.
Cocoa--but not tea--consumption appears to be associated with blood pressure reductions comparable with those achieved with a [beta]-blocker or an angiotensin-converting enzyme inhibitor
Michael's Hospital in Toronto, and colleagues used linked clinical and administrative databases to compare clinical outcomes and medication adherence for patients prescribed one angiotensin-converting enzyme inhibitor
or angiotensin II-receptor blocker plus one thiazide diuretic, either as a single-pill FDC or as a multi-pill combination.
In clinical trials, the first drug in this class, sacubitril/valsartan (Entresto[TM]), reduced the number of cardiovascular deaths and heart failure hospitalizations by 20 percent, compared with the angiotensin-converting enzyme inhibitor
(ACEI) enalapril (Vasotec[R]).
Prognostic impact of angiotensin-converting enzyme inhibitor
therapy in diastolic heart failure.